Charles River Laboratories International (CRL) Shares Outstanding (2009 - 2026)

Charles River Laboratories International has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $47.7 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 3.01% year-over-year to $47.7 million in Q2 2026; TTM through Jun 2026 was $47.7 million, a 3.01% decrease from a year earlier, with the FY2025 full-year figure at $49.2 million, down 3.76% from the prior year.
• Shares Outstanding (Entity) was $47.7 million for Q2 2026 at Charles River Laboratories International, down from $48.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $51.6 million in Q2 2024, with the low at $47.7 million in Q2 2026.
• Average Shares Outstanding (Entity) over 5 years is $50.4 million, with a median of $50.9 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) advanced 1.16% in 2022, then dropped 4.66% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $50.9 million in 2022, then rose by 0.77% to $51.3 million in 2023, then decreased by 0.38% to $51.1 million in 2024, then slipped by 3.76% to $49.2 million in 2025, then slipped by 3.03% to $47.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $47.7 million (Q2 2026), $48.2 million (Q1 2026), and $49.2 million (Q4 2025), per Business Quant data.